Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetics-Supported Mainstream Testing Improves Access and Efficiency for Patients With Breast Cancer.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

Dynamic monitoring of antibody drug conjugates targeting TROP2 or HER2 in breast cancer using circulating tumor cells.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Safety and antitumour activity of ipatasertib combined with endocrine therapy and a CDK4/6 inhibitor in HR+/HER2- metastatic breast cancer (TAKTIC): a single-centre, open-label, phase 1b trial.

The Lancet. Oncology·2026
Same author

Author Correction: HER2 expression identifies dynamic functional states within circulating breast cancer cells.

Nature·2026
Same author

ATR Safeguards Epithelial-to-Mesenchymal Transition by Countering R-loops and Enabling Transcription Reprogramming.

The Journal of clinical investigation·2026
Same author

Circulating Tumor Cells Predict Response to the DLL3-Targeting Bispecific Antibody Tarlatamab.

Cancer discovery·2026

Related Experiment Video

Updated: Jun 14, 2026

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
11:18

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research

Published on: January 22, 2011

16.1K

Deploying blood-based cancer screening.

Douglas S Micalizzi1,2, Lecia V Sequist2, Daniel A Haber1,2,3

  • 1Krantz Family Center for Cancer Research, Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA, USA.

Science (New York, N.Y.)
|January 25, 2024
PubMed
Summary

Artificial intelligence (AI) risk assessment shows promise for personalized blood tests that screen for multiple cancer types. This approach may lead to earlier cancer detection and tailored screening strategies.

More Related Videos

Real-time Cytotoxicity Assays in Human Whole Blood
08:27

Real-time Cytotoxicity Assays in Human Whole Blood

Published on: November 7, 2014

12.2K
Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples
08:49

Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples

Published on: January 13, 2023

1.9K

Related Experiment Videos

Last Updated: Jun 14, 2026

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
11:18

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research

Published on: January 22, 2011

16.1K
Real-time Cytotoxicity Assays in Human Whole Blood
08:27

Real-time Cytotoxicity Assays in Human Whole Blood

Published on: November 7, 2014

12.2K
Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples
08:49

Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples

Published on: January 13, 2023

1.9K

Area of Science:

  • Biomedical informatics
  • Oncology
  • Genomics

Background:

  • Multicancer screening aims to detect various cancers early.
  • Current screening methods often lack personalization and can be invasive.
  • Emerging technologies offer new avenues for non-invasive cancer detection.

Purpose of the Study:

  • To explore the potential of AI in developing personalized risk assessment models.
  • To evaluate the feasibility of blood-based screening for multiple cancers.
  • To identify AI-driven strategies for improving early cancer detection.

Main Methods:

  • Utilizing artificial intelligence algorithms for risk stratification.
  • Analyzing large-scale datasets including genomic and clinical information.
  • Developing predictive models for blood-based biomarker identification.

Main Results:

  • AI-based models demonstrated capability in assessing individual cancer risk.
  • Personalized risk profiling using blood markers is a viable strategy.
  • The approach holds potential for identifying individuals at high risk for specific cancers.

Conclusions:

  • AI-powered risk assessment can facilitate personalized, blood-based multicancer screening.
  • This technology may significantly enhance early cancer detection rates.
  • Future research should focus on clinical validation and implementation of AI tools in screening programs.